Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services Knowpia

More than 130 medical devices were approved by the FDA since January 2018, while several are currently being evaluated across more than 9,500 (active) clinical trials, worldwide. Even though technical innovation has enabled the development of a variety of versatile medical devices, product approval, given stringent regulatory standards, is still a concern.

To order this 550+ page report, which features 245+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html

The USD 820 million (by 2030) financial opportunity within the contract regulatory affairs-management services market for medical devices has been analyzed across the following segments:

§ Medical Device Class

Class I
Class II
Class III

§ Therapeutic Area

Cardiovascular Disorders
CNS Disorders
Metabolic Disorders
Oncological Disorders
Ophthalmological Disease
Orthopedic Disorders
Pain Disorders
Respiratory Disorders
Others

§ Type of Regulatory Affairs Service

Pharmacies GAP-Analysis
Pharmacies Legal Representation
Pharmacies Notified Body Selection
Product Labelling-related Services
Product Registration and Clinical Trial Applications
Regulatory Document Submissions
Regulatory Writing and Publishing
Risk Management-related Services
Technical Dossier Set-up
Vigilance & Medical Device Report

§ Key Geographical Regions

North America
Europe
Asia-Pacific and Rest of the World

The Medical Device CROs for Regulatory Affairs Management Market, 2019-2030.” report features the following companies, which we identified to be key players in this domain:

§ CTI Clinical Trial and Consulting Services

§ CROMSOURCE

§ ICON

§ Intertek

§ Medpace

§ MIC Medical

§ North American Science Associates (NAMSA)

§ Parexel

§ PharmaLex

§ Premier Research

§ Société Générale de Surveillance (SGS)

§ Underwriters Laboratory (UL)